CRMD Q2 2022 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21,253+159.5% YoY

Gross Profit

$20,92198.4% margin

Operating Income

-$8M-38773.1% margin

Net Income

-$8M-35782.4% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+178.3%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$68M

Total Liabilities

$6M

Stockholders' Equity

$62M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,253	$8,191	+159.5%
Gross Profit	$20,921	-$6,235	+435.5%
Operating Income	-$8M	-$6M	-40.1%
Net Income	-$8M	-$5M	-64.1%